StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report issued on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance SRNE opened at $0.01 on Thursday. The stock’s 50-day moving average price is $0.01 and its 200 day moving average price […]